Bone Biologics Corp Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bone Biologics Corp quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Bone Biologics Corp Return On Equity for the quarter ending September 30, 2024 was -125 %, a 12.8% increase year-over-year.
  • Bone Biologics Corp annual Return On Equity for 2023 was -236 %, a 773% decline from 2022.
  • Bone Biologics Corp annual Return On Equity for 2022 was -27 %, a 256% decline from 2021.
  • Bone Biologics Corp annual Return On Equity for 2021 was 17.3 %, a 23.7% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -236 -209 -773% Jan 1, 2023 Dec 31, 2023
2022 -27 -44.3 -256% Jan 1, 2022 Dec 31, 2022
2021 17.3 +3.31 +23.7% Jan 1, 2021 Dec 31, 2021
2020 14 -17.1 -55.1% Jan 1, 2020 Dec 31, 2020
2019 31.1 -21.4 -40.8% Jan 1, 2019 Dec 31, 2019
2018 52.5 -25.7 -32.8% Jan 1, 2018 Dec 31, 2018
2017 78.1 -354 -81.9% Jan 1, 2017 Dec 31, 2017
2016 433 -34.7 -7.42% Jan 1, 2016 Dec 31, 2016
2015 467 +344 +278% Jan 1, 2015 Dec 31, 2015
2014 124 +48 +63.5% Jan 1, 2014 Dec 31, 2014
2013 75.6 +15.7 +26.2% Jan 1, 2013 Dec 31, 2013
2012 59.9 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.